PROVISION OF TUMOUR PROFILING TEST

Award

Buyers

Value

£121,500

Suppliers

Classifications

  • Diagnostic supplies

Tags

  • award
  • contract

Published

2 years ago

Description

Nice guidelines recommend Endopredict, Oncotype DX or Prosigna Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer.  Of these 3 tests it has been confirmed that Oncotype DX is the only one available under the framework, Contract Ref. Pathology and Point of Care Testing, Associated Equipment, Instruments, Consumables and Accessories and Managed Services (2019/S 212-519575). A direct award has been made to Exact Sciences for Oncotype DX for the following reason: Specialist  expertise is required and only available from one source.

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download

  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Organisation

NHS South West - Acutes

Regional or local authority

Sam Squirrell

[email protected]

+44 1803653358

[email protected]

+44 2030318087

Timeline complete

Publish
Bid
Evaluate
Award
Complete